We paid a visit to Mentis Cura, a leading edge Icelandic company that has developed early diagnostics for several forms of dementia. Its proprietary technology uses data produced by simple electroencephalograms to detect the potential for cognitive impairment and dementia and for detecting cholinergic activity. In layman’s terms, it helps health care providers detect early stages of dementia and the likely responsiveness to its treatment. Mentis Cura has established relationships with some of the world’s leading research institutions, and we will be pleased to assist in expanding those relationships to the United States.
